Discover / Book
Her-2

Her-2

Robert Bazell · 1998 · 214 pages

HER-2 geneBreastCancerTrastuzumabHER-2 proteinImmunotherapy

As an Amazon Associate we earn from qualifying purchases. Some book links are affiliate links; you pay the same price and we may earn a small commission.

About this book

Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer free. This is the biography of Her-2, Herceptin, the drug that provoked dramatic responses in Barbara and other women in the trials that offers promise for hundreds of thousands of women.

Appears in these reading paths

Related reading guides

Reader reviews

Ratings and notes from readers — tagged with how deep into the subject they were.

Loading reviews…

Discussion